Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma

PurposeThe elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the devel...

Full description

Bibliographic Details
Main Authors: Michał Fiedorowicz, Marlena Wełniak-Kamińska, Maciej Świątkiewicz, Jarosław Orzeł, Tomasz Chorągiewicz, Mario Damiano Toro, Robert Rejdak, Piotr Bogorodzki, Paweł Grieb
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.573238/full
_version_ 1818989514016686080
author Michał Fiedorowicz
Michał Fiedorowicz
Marlena Wełniak-Kamińska
Marlena Wełniak-Kamińska
Maciej Świątkiewicz
Maciej Świątkiewicz
Jarosław Orzeł
Jarosław Orzeł
Tomasz Chorągiewicz
Mario Damiano Toro
Mario Damiano Toro
Robert Rejdak
Piotr Bogorodzki
Piotr Bogorodzki
Paweł Grieb
author_facet Michał Fiedorowicz
Michał Fiedorowicz
Marlena Wełniak-Kamińska
Marlena Wełniak-Kamińska
Maciej Świątkiewicz
Maciej Świątkiewicz
Jarosław Orzeł
Jarosław Orzeł
Tomasz Chorągiewicz
Mario Damiano Toro
Mario Damiano Toro
Robert Rejdak
Piotr Bogorodzki
Piotr Bogorodzki
Paweł Grieb
author_sort Michał Fiedorowicz
collection DOAJ
description PurposeThe elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the development of glaucoma. The aims of this study were to quantify changes in ocular morphology in DBA/2J mice that develop spontaneous, age-dependent, pigmentary glaucoma and to check the possible correlation of these parameters with IOP.MethodEye morphology was evaluated with MRI in DBA/2J, DBA/2J-Gpnmb+/SjJ, and C57BL/6J female mice ages 3, 6, 9, 12, and 15 months. The animals were anesthetized with isoflurane. A planar receive-only surface coil (inner diameter = 10 mm) was placed over each animal’s left eye and the image was acquired with a 7T small animal-dedicated magnetic resonance tomograph and T2-weighted TurboRARE sequence. Ocular dimensions were manually quantitated using OsiriX software. IOP was measured with rebound tonometry.ResultsIn the control animals, no age-related changes in the ocular morphology were noted. Since 6 months of age, the anterior chamber deepening and elongation of the eyeballs of DBA/2J mice was detectable. We found a significant, positive correlation between IOP and axial length, anterior chamber area, or anterior chamber width in C57BL/6J mice but not in DBA/2J mice. However, after excluding the measurements performed in the oldest DBA/2J mice (i.e. analyzing only the animals ages 3 to 12 months), we demonstrated a significant positive correlation between IOP and anterior chamber width.ConclusionHigh-resolution magnetic resonance imaging of the eye area in mice enables reproducible and consistent measures of key dimensions of the eyeball. We observed age-dependent alterations in the eye morphology of DBA/2J mice that mostly affected the anterior chamber. We also demonstrated a correlation between some of the ocular dimensions and the IOP of C57Bl/6J mice and DBA/2J mice with moderately advanced glaucomatous pathology.
first_indexed 2024-12-20T19:39:41Z
format Article
id doaj.art-7ea33d103f52403a9c3591c8f835b068
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T19:39:41Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-7ea33d103f52403a9c3591c8f835b0682022-12-21T19:28:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-09-011110.3389/fphar.2020.573238573238Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary GlaucomaMichał Fiedorowicz0Michał Fiedorowicz1Marlena Wełniak-Kamińska2Marlena Wełniak-Kamińska3Maciej Świątkiewicz4Maciej Świątkiewicz5Jarosław Orzeł6Jarosław Orzeł7Tomasz Chorągiewicz8Mario Damiano Toro9Mario Damiano Toro10Robert Rejdak11Piotr Bogorodzki12Piotr Bogorodzki13Paweł Grieb14Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandSmall Animal Magnetic Resonance Imaging Laboratory, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandDepartment of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandSmall Animal Magnetic Resonance Imaging Laboratory, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandDepartment of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandSmall Animal Magnetic Resonance Imaging Laboratory, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandSmall Animal Magnetic Resonance Imaging Laboratory, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandFaculty of Electronics and Information Technology, Warsaw University of Technology, Warsaw, PolandDepartment of General Ophthalmology, Medical University of Lublin, Lublin, PolandDepartment of General Ophthalmology, Medical University of Lublin, Lublin, PolandFaculty of Medical Sciences, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, PolandDepartment of General Ophthalmology, Medical University of Lublin, Lublin, PolandSmall Animal Magnetic Resonance Imaging Laboratory, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandFaculty of Electronics and Information Technology, Warsaw University of Technology, Warsaw, PolandDepartment of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, PolandPurposeThe elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the development of glaucoma. The aims of this study were to quantify changes in ocular morphology in DBA/2J mice that develop spontaneous, age-dependent, pigmentary glaucoma and to check the possible correlation of these parameters with IOP.MethodEye morphology was evaluated with MRI in DBA/2J, DBA/2J-Gpnmb+/SjJ, and C57BL/6J female mice ages 3, 6, 9, 12, and 15 months. The animals were anesthetized with isoflurane. A planar receive-only surface coil (inner diameter = 10 mm) was placed over each animal’s left eye and the image was acquired with a 7T small animal-dedicated magnetic resonance tomograph and T2-weighted TurboRARE sequence. Ocular dimensions were manually quantitated using OsiriX software. IOP was measured with rebound tonometry.ResultsIn the control animals, no age-related changes in the ocular morphology were noted. Since 6 months of age, the anterior chamber deepening and elongation of the eyeballs of DBA/2J mice was detectable. We found a significant, positive correlation between IOP and axial length, anterior chamber area, or anterior chamber width in C57BL/6J mice but not in DBA/2J mice. However, after excluding the measurements performed in the oldest DBA/2J mice (i.e. analyzing only the animals ages 3 to 12 months), we demonstrated a significant positive correlation between IOP and anterior chamber width.ConclusionHigh-resolution magnetic resonance imaging of the eye area in mice enables reproducible and consistent measures of key dimensions of the eyeball. We observed age-dependent alterations in the eye morphology of DBA/2J mice that mostly affected the anterior chamber. We also demonstrated a correlation between some of the ocular dimensions and the IOP of C57Bl/6J mice and DBA/2J mice with moderately advanced glaucomatous pathology.https://www.frontiersin.org/article/10.3389/fphar.2020.573238/fullglaucomaocular dimensionsocular biomechanicsintraocular pressureDBA/2JMRI
spellingShingle Michał Fiedorowicz
Michał Fiedorowicz
Marlena Wełniak-Kamińska
Marlena Wełniak-Kamińska
Maciej Świątkiewicz
Maciej Świątkiewicz
Jarosław Orzeł
Jarosław Orzeł
Tomasz Chorągiewicz
Mario Damiano Toro
Mario Damiano Toro
Robert Rejdak
Piotr Bogorodzki
Piotr Bogorodzki
Paweł Grieb
Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Frontiers in Pharmacology
glaucoma
ocular dimensions
ocular biomechanics
intraocular pressure
DBA/2J
MRI
title Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_full Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_fullStr Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_full_unstemmed Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_short Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_sort changes of ocular dimensions as a marker of disease progression in a murine model of pigmentary glaucoma
topic glaucoma
ocular dimensions
ocular biomechanics
intraocular pressure
DBA/2J
MRI
url https://www.frontiersin.org/article/10.3389/fphar.2020.573238/full
work_keys_str_mv AT michałfiedorowicz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT michałfiedorowicz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT marlenawełniakkaminska changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT marlenawełniakkaminska changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT maciejswiatkiewicz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT maciejswiatkiewicz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT jarosławorzeł changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT jarosławorzeł changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT tomaszchoragiewicz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT mariodamianotoro changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT mariodamianotoro changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT robertrejdak changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT piotrbogorodzki changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT piotrbogorodzki changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT pawełgrieb changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma